Country Club Bank Invests $4.08 Million in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Country Club Bank bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 150,976 shares of the medical instruments supplier's stock, valued at approximately $4,084,000. Country Club Bank owned 0.07% of DENTSPLY SIRONA as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in XRAY. First Eagle Investment Management LLC boosted its position in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock valued at $325,571,000 after acquiring an additional 3,283,965 shares during the last quarter. SG Americas Securities LLC raised its holdings in shares of DENTSPLY SIRONA by 2,959.1% during the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier's stock valued at $45,584,000 after buying an additional 1,328,525 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock valued at $110,118,000 after buying an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP raised its holdings in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier's stock valued at $186,996,000 after buying an additional 1,046,105 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. raised its holdings in shares of DENTSPLY SIRONA by 398.2% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 1,025,200 shares of the medical instruments supplier's stock valued at $34,026,000 after buying an additional 819,400 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $1.10 during mid-day trading on Friday, reaching $23.31. 3,688,608 shares of the stock traded hands, compared to its average volume of 2,965,741. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The business's 50-day moving average is $25.22 and its 200-day moving average is $26.47. The stock has a market capitalization of $4.73 billion, a PE ratio of -27.10, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 12-month low of $22.85 and a 12-month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to analysts' expectations of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.51 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.98 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.75%. The ex-dividend date of this dividend was Friday, September 27th. DENTSPLY SIRONA's payout ratio is -74.42%.

Analyst Ratings Changes

XRAY has been the topic of a number of analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research note on Thursday, July 18th. Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research note on Friday. Evercore ISI decreased their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Finally, Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating on the stock in a research note on Monday, July 22nd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $32.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.